OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2020
(2)
2018
(2)
2025
(1)
2021
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care.
Not available
S-EPMC6306758
|
biostudies-literature
Cite
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care.
Not available
S-EPMC6107171
|
biostudies-literature
Cite
Efficacy and safety of dapagliflozin in patients with CKD: real-world experience in 93 Italian renal clinics.
Not available
S-EPMC11744308
|
biostudies-literature
Cite
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study.
Not available
S-EPMC8221239
|
biostudies-literature
Cite
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.
Not available
S-EPMC7446618
|
biostudies-literature
Cite
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.
Not available
S-EPMC7521934
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets